La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « P. J. Blanchet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P. J. Bedard < P. J. Blanchet < P. J. Burtis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
002578 (2008) F. Paquet [Canada] ; M. A. Bedard [Canada] ; M. Levesque [Canada] ; P. L. Tremblay [Canada] ; M. Lemay [Canada] ; P. J. Blanchet [Canada] ; P. Scherzer [Canada] ; S. Chouinard [Canada] ; J. Filion [Canada]Sensorimotor adaptation in Parkinson's disease : evidence for a dopamine dependent remapping disturbance
003B15 (2000) F. Calon [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; T. T. Di Paolo [Canada] ; P. J. Bedard [Canada]Molecular basis of levodopa-induced dyskinesias
003B47 (2000) F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]125I-CGP 64213 binding to GABAB receptors in the brain of monkeys : Effect of MPTP and dopaminomimetic treatments
003D84 (1999) P. J. Blanchet [Canada]Rationale for use of dopamine agonists in Parkinson's disease : Review of ergot derivatives
003E22 (1999) F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys : effects on basal ganglia GABAA/ benzodiazepine receptor complex and GABA content
004329 (1997) M. Goulet [Canada] ; M. Morissette [Canada] ; F. Calon [Canada] ; P. J. Blanchet [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression : In situ hybridization histochemical analysis
004546 (1996) P. J. Blanchet [Canada] ; R. Grondin [Canada] ; R. Bédard [Canada]Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates
004577 (1996) P. J. Blanchet [Canada] ; P. Allard [Canada] ; L. Gregoire [Canada] ; F. Tardif [Canada] ; P. J. Bedard [Canada]Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients
004588 (1996) J.-J. Soghomonian [Canada] ; S. Pedneault [Canada] ; P. J. Blanchet [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys
004594 (1996) M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada]Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys
004595 (1996) P. J. Blanchet [Canada] ; R. Grondin ; P. J. BedardDyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
004597 (1996) P. J. Blanchet [Canada] ; R. Grondin [Canada] ; P. J. Bedard [Canada] ; K. Shiosaki [États-Unis] ; D. R. Britton [États-Unis]Dopamine D1 receptor desensitization profile in MPTP-lesioned primates
004749 (1995) F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; J. C. Martel [Canada] ; M. F. Piercey [États-Unis] ; P. J. Be Dard [Canada] ; T. Di Paolo [Canada]Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex
004815 (1995) F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet ; J. C. Martel [Canada] ; M. F. Piercey ; P. J. Bedard ; T. Di Paolo [Canada]Levodopa or D2 agonist induced dyskinesia in MPTP monkeys : correlation with changes in dopamine and GABAA receptors in the striatopallidal complex
004817 (1995) P. J. Blanchet ; B. Gomez-Mancilla [Canada] ; T. Di Paolo ; P. J. BedardIs striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia ?
004A72 (1994) P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. BedardExcitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "P. J. Blanchet" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "P. J. Blanchet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    P. J. Blanchet
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022